James Michael Edwards - Nov 5, 2024 Form 4 Insider Report for bioAffinity Technologies, Inc. (BIAF)

Role
VP and CFO
Signature
/s/ Maria Zannes, as attorney-in-fact for James Michael Edwards
Stock symbol
BIAF
Transactions as of
Nov 5, 2024
Transactions value $
$0
Form type
4
Date filed
11/5/2024, 07:05 PM
Previous filing
Sep 20, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIAF Common Stock Award $0 +100K +716.54% $0.00 114K Nov 5, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of restricted shares, which shares will vest 25% on each of (1) the grant date, (2) the one year anniversary of the grant date, (3) the two year anniversary of the grant date and (4) the three year anniversary of the grant date.